Hepatitis C virus infection and lymphomas
β Scribed by Semra Paydas
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 37 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
I read with great interest the article by De Sandose et al. 1 They reported 5.9% anti-HCV prevalence in cases with NHL and the prevalence was 3.8% in controls. OR was highest (35.98) in cases with low-grade B-cell lymphomas. They concluded that HCV infection is associated with an increased risk of lymphoid neoplasms. We studied in southern Turkey HCV prevalence in 3 different studies. In our first study, anti-HCV antibody was examined in 228 cases with lymphoproliferative diseases; 26 of them (11.40%) were found to be positive, which was higher than the controls. Among these, 98 had NHL and 9 of them (11.11%) was found to be positive for anti-HCV antibody. OR for anti-HCV was 24.09. 2 In our second study, anti-HCV antibody was examined in 223 cases with NHL and it was found to be positive in 18 (8.1%). Common OR was 34.56 and corrected OR was 19.07. Among these cases, HCV-RNA was studied in 67 cases and 21 of them were found to be
π SIMILAR VOLUMES
## Abstract A high prevalence of hepatitis C virus (HCV) infection in patients with Bβcell nonβHodgkin's lymphoma (BβNHL) has been reported in some, but not all, studies, and the association showed a strong regional variation. We conducted a systematic review of the prevalence of HCV infection in c
## Abstract We investigated whether there was an association between GBVβC viremia and the development of nonβHodgkin lymphoma (NHL) in 553 NHL cases and 438 controls from British Columbia, Canada. Cases were aged 20β79, diagnosed between March 2000 and February 2004, and resident in Greater Vancou
The aim of this study was to evaluate the association between hepatitis C virus (HCV) infection and non-Hodgkin's lymphoma (NHL), multiple myeloma (MM), thyroid cancer (TC), chronic lymphatic leukemia (CLL), acute lymphatic leukemia (ALL), and Hodgkin's lymphoma (HL). A Swedish cohort of 27,150 HCV-